Emerging Research

What Gene is Driving My Cancer?

Dr. Drilon explains the importance of genomic testing for cancer and how understanding the dna of the cancer affects treatment.

Alexander Drilon, MD, Andrew Schorr

When Will We Have Safer and More Effective AML Treatments?

New targeted treatments for acute myeloid leukemia (AML) may be safer, more effective and help expand access for under-served populations.

Latest News

ASH 2020 AML Roundtable: New Developments & Patient Access

Courtney DiNardo, M.D., MSCE, Eunice Wang, MD, Jessica Altman, MD, Andrew Schorr

Are Blood Cancers Hereditary?

Andrew Schorr, Courtney DiNardo, M.D., MSCE

What Does The Viale-A Study Mean For Older AML Patients?

Andrew Schorr, Courtney DiNardo, M.D., MSCE

New Study May Revolutionize the Way We Detect Cancer

AML News to Discuss With Your Doctor

Naveen Pemmaraju, MD, Andrew Schorr

Genetic Research Leads to Progress in Survival Statistics

Tapan M. Kadia, MD, Andrew Schorr

AML Treatment Developments: Key Takeaways From ASH 2018

Beth Kart Probert, Naval G. Daver, MD

Emerging Research and Promising AML Treatment Approaches

Leah Szumita, MS, RN, Steve Buechler, Beth Kart Probert, Naval G. Daver, MD

Clinical advances in acute myeloid leukemia

Dr Christoph Röllig